semaglutide microdosing chart Our Clinic’s Chart: Real Doses from 200+ Patients (Starting at 0.05 mg) Semaglutide dosage chart in units:

SURMOUNT-5 was a 72-week, open-label, Phase 3b randomised trial of 751 adults with obesity but without diabetes, comparing maximum-tolerated tirzepatide (10 or 15 mg) against maximum-tolerated semaglutide (1.7 or 2.4 mg)

[15] The immediate-release and extended release variants of salts of both isomers reach peak plasma concentrations at 3 hours and 7 hours post-dose respectively

Medications include compounded semaglutide and tirzepatide (503B pharmacy), brand-name Wegovy and Zepbound with PA support, and non-GLP-1 alternatives (topiramate, bupropion, metformin, orlistat) if you are ineligible

Iron and zinc: At the doses discussed in the essential vitamins section

e-Pub 2025

Impact of different statin types/doses on new-onset diabetes: meta-analysis